Abstract The solute removal characteristics and Introduction haemocompatibility of low-flux dialysers containing CuprophanA, cellulose acetate, polymethylmeth-Although highly permeable membranes are readily acrylate ( PMMA), and polycarbonate-polyether available, most dialysis treatments are still performed (GambraneA) membranes were compared in a mul-with dialysers containing so-called low-flux memticentre cross-over clinical trial. While all four dialysers branes, that are characterized by water permeabilities provided comparable removal of urea and creatinine, less than 10 ml/h/m2/mmHg. Such dialysers can prothe dialyser containing PMMA membrane showed a vide excellent long-term outcomes [1]; however, some reduced ability to remove phosphate compared to that investigators have argued that their limited permeabilcontaining Cuprophan membrane. Significant b 2 -ity and generally lesser haemocompatibility compared microglobulin removal was obtained with the dialyser to high-flux membranes may contribute to patient containing Gambrane membrane, whereas the other morbidity [2 ]. For example, removal of b 2 -microglobuthree dialysers had no impact on plasma b 2 -micro-lin, which accumulates in the plasma of patients with globulin concentrations. The ability to activate renal failure and is the major constituent of amyloid complement, measured as changes in the plasma con-deposits associated with carpal-tunnel syndrome, cystic centrations of C3a des Arg and the terminal bone lesions, and disabling arthropathies in long-term haemodialysis patients [3 ] , is thought to require memcomplement complex, and to produce leukopenia was branes with high hydraulic permeability [4] . In these greater for the dialyser containing Cuprophan memarguments, dialysers containing low-flux membranes brane than for the other three. The ability to activate tend to be treated as a homogeneous group. However, complement and cause leukopenia was not consistent low-flux membranes may be fabricated from various among the remaining three dialysers and the degree of materials, including cellulose, modified cellulose, and leukopenia could not be predicted from the level of synthetic polymers, have symmetric or asymmetric complement activation. Neutrophil degranulation, as cross-sections, be homogeneous or segmented in comindicated by the release of elastase-a 1 -proteinase inhibposition, and be configured as hollow fibres or flat itor, occurred to a greater extent with the dialysers sheets. As a consequence, the performance of dialysers containing Cuprophan and Gambrane membranes. containing these membranes is likely to vary. To estabNone of the dialysers was overtly thrombogenic as lish the range of performance possible with low-flux judged by changes in platelet count and plasma concenmembranes, we compared and contrasted the solute trations of the thrombin-antithrombin III complex.
inclusion, patients must have been stable on thrice-weekly the blood flow to 50 ml/min. Additional samples for measuring clotting times were drawn before the heparin loading haemodialysis for at least 2 months and have a plasma b 2 -microglobulin concentration of 30 mg/l, or greater. Patients dose was administered and after 2 h (centres 2 and 3) or postdialysis (centre 1). with ongoing infections or neoplasms were excluded from consideration. The study was approved by the human studies committees of St Orsola University Hospital, the University Analytical methods of Louisville, and Klinikum Grosshadern, and informed consent was obtained from all patients before their enrolment Plasma concentrations of urea, creatinine and inorganic in the study.
phosphorus, blood cell counts, and haematocrit were determined by routine clinical laboratory methods. Plasma concentrations of C3a des Arg (Quidel, San Diego, CA, USA),
Experimental design
the terminal complement complex, C5b-9, ( TCC) [5] , thrombin-antithrombin III complex ( TAT ) (Behring, Patients were treated with dialysers containing four diÂerent Marburg, Germany), elastase-a 1 -proteinase inhibitor membranes in either hollow-fibre or flat-plate format. Two (Merck, Darmstadt, Germany), and b 2 -microglobulin membranes were cellulosic (regenerated cellulose and cellu-(Pharmacia, Uppsala, Sweden) were determined by enzyme lose acetate) and two were synthetic ( polymethylmethacrylate immunoassay. Clotting times were determined by each and polycarbonate-polyether) ( Table 1 ). All dialysers had a centre's routine method, including activated partial thromlow hydraulic permeability (ultrafiltration coeÃcients in the boplastin time (centre 1), whole blood partial thromboplastin range 3-8 ml/h/m2/mmHg) and were selected to have comtime ( Endpoint, Edison Institute, Edison, NJ, USA) parable solute permeabilities based on the manufacturer's (centre 2 ), and recalcified activated clotting time ( Hemotec, performance specifications for urea and creatinine. Each of Englewood, CO, USA) (centre 3). the dialysers was used for six consecutive treatments, the order being randomized by drawing lots. Dialysers were prepared for use according to the manufacturer's instructions Data analysis and were not reused.
All treatments were performed with volume control sys-With the exception of b 2 -microglobulin, cell counts and tems delivering 500-600 ml/min of 35 mM bicarbonate solute concentrations are presented uncorrected for haemodialysate. Treatment times and blood flow rates were indi-concentration due to fluid removal. b 2 -microglobulin concenvidualized for each patient to achieve a Kt/V of approxi-trations were corrected for haemoconcentration using the mately 1.2, and were kept constant for each patient method of Bergström and Wehle [6 ] . Assuming that b 2 -throughout the study. Fluid removal rates depended on the microglobulin is removed from a single pool equivalent to clinical needs of the patient. Anticoagulation was performed extracellular fluid and that this volume can be taken as 20% with heparin, and doses were prescribed to achieve a 50% of postdialysis body weight, the amount of b 2 -microglobulin increase in activated clotting time above the predialysis value. removed during dialysis was estimated from: The routine heparinization procedure at each centre was b 2 -microglobulin removed=C Pre *( Wgt Post *0.2+DBW ) maintained during the study. At Centre 1, an initial loading dose of heparin was administered by including 20 000 IU of −C Post *Wgt Post *0.2 heparin in the saline used to prepare the dialyser; a second where C is the b 2 -microglobulin concentration, Wgt is body bolus was administered in some patients after 1 h of dialysis.
weight, and DBW is the pre-to post-dialysis change in At Centres 2 and 3, heparin was administered as a loading body weight. dose and constant infusion. The ability of an individual
The delivered dose of dialysis, expressed in terms of a patient's heparin dose to achieve the target increase in single pool Kt/V for urea, was estimated using the following clotting time was checked prior to commencing the study, formula derived by Daugirdas [7] : and verified by measuring activated clotting times for treatments during which blood samples were collected as Kt/V=−ln(C Pre /C Post −0.008*t) described below. +(4−3.5*C Pre /C Post )*UF/Wgt Post Blood samples were drawn during the sixth treatment with each dialyser to assess the impact of the dialyser on plasma where UF is the ultrafiltered volume.
Data are presented as mean±standard deviation for n levels of small (urea, creatinine, inorganic phosphorus) and large ( b 2 -microglobulin) solutes and haemocompatibility. observations. DiÂerences between centres and dialysers, and at diÂerent times during dialysis for each dialyser, were Blood was drawn after needle insertion ( Pre), after 15 min of dialysis from the aÂerent (15A) and the eÂerent ( 15V ) evaluated by analysis of variance. When data were not normally distributed, a logarithmic transformation or approblood lines of the dialyser, and post-dialysis from the aÂerent line (Post). The Post sample was drawn 2 min after reducing priate non-parametric tests were used. Where significant Comparison of low-flux dialyser membranes 967 diÂerences were found (P<0.05), diÂerences between indi-anticoagulation was similar at the three centres and vidual centres, dialysers, or times were tested using the Tukey after adjusting for centre diÂerences, there was no test. Statistical testing was performed using SigmaStat diÂerence in the level of anticoagulation for the four (Jandel Scientific, San Rafael, CA, USA).
dialysers.
Small-solute removal

Results
Small-molecule removal was assessed by comparing Dialysis treatments the pre-to post-dialysis reduction in concentration of urea, creatinine, and inorganic phosphorus ( Table 4 ) . Thirty-seven patients were enrolled in the study. Two
Patients at centre 1 had higher predialysis concentrapatients withdrew very early in the study and are not tions of urea than patients at the other centres (P= included in the presentation of results. A third patient 0.0024), while predialysis concentrations of creatinine withdrew after completing treatments on three of the were higher for patients at centre 2 (P<0.0001). dialysers; data from this patient are included in the Predialysis concentrations of inorganic phosphorus results. None of the three patients who withdrew did diÂered between all three centres (P<0.0001). When so for reasons related to the study. Details of the these centre eÂects were taken into account, there was patients are given in Table 2 . Patients diÂered significno diÂerence in the predialysis concentration of urea, antly in age between the three centres ( F=3.81, P= creatinine, or inorganic phosphorus between the four 0.0328); otherwise there were no diÂerences in patient dialysers. All four dialysers produced comparable demographics between centres. In spite of diÂerences decreases in the concentrations of urea and creatinine in erythropoietin dosing protocols between centres, (Table 4 ) . However, the decrease in inorganic phosthere were no diÂerences between centres or dialysers phorus diÂered between the four dialysers (P=0.0177). in predialysis haematocrit, which overall averaged
The decrease obtained with the dialyser containing 30.4±3.1%.
PMMA membrane was significantly less than that All dialyses were clinically uneventful. Details of the obtained with the dialyser containing Cuprophan memtreatment conditions are given in Table 3 . Centre 3 brane ( 35±11 vs 45±14%), while the decreases with used longer treatment times than the other two centres the dialysers containing the other two membranes were and blood flow rates also diÂered between the centres.
intermediate between these two and did not diÂer After adjusting for the centre diÂerences, however, from them. Kt/V for urea decreased significantly with treatment time, blood flow rate, and ultrafiltered increasing body weight (DKt/V=−0.0082/kg, r= volume did not diÂer between the four dialysers, 0.553, n=136, P<0.0001), but was independent of indicating compliance with the study protocol. The centre or the choice of dialyser. This finding suggests protocol used at Centre 1 prevented calculation of the that the delivered dose of dialysis for large patients is total amount of heparin administered to patients at limited by available treatment times, in spite of the use that centre. Patients at Centre 3 received more heparin of urea kinetic modelling. than patients at Centre 2. This diÂerence persisted even after correcting for diÂerences in treatment time between the two centres. Nevertheless, the level of Removal of b 2 -microglobulin
The pre-to postdialysis change in plasma concentra- removed with the dialyser containing Gambrane membrane was estimated to be 132±94 mg, again signific1Data are presented as mean±SD.
antly diÂerent from the negligible amount estimated 2Includes amyloidosis, analgesic nephropathy, gouty nephropathy, to be removed with the other three dialysers (−5 mg, haemolytic uraemic syndrome, obstructive uropathy, polycystic −8 mg, and 5 mg for the dialysers containing kidney disease, pyelonephritis, Schönlein-Henoch purpura, vasculitis, and unknown.
Cuprophan, cellulose acetate, and PMMA membranes respectively). The ability of Gambrane membrane to (centre 1, 215±127 ng/ml; centre 2, 159±59 ng/ml; and centre 3, 272±161 ng/ml ); however, there was no remove b 2 -microglobulin resulted in a significantly diÂerence between dialysers after adjusting for centre lower predialysis plasma b 2 -microglobulin concentraeÂects (P=0.401). C3a des Arg concentrations tion after five treatments with that membrane comwere significantly increased after 15 min of dialysis pared to the other membranes (F=10.1, P<0.001) (P<0.0001) ( Table 6 ). The increase was transient; ( Table 5 ) .
however, post-dialysis C3a des Arg concentrations for the dialyser with Cuprophan membrane remained sigHaemocompatibility nificantly greater than predialysis values. The magniPredialysis plasma C3a des Arg concentrations diÂered tude of the increase depended on the dialyser (P<0.0001). The dialyser containing Cuprophan memslightly, but significantly (P=0.0001) between centres (P<0.
Predialysis leukocyte counts did not diÂer between centres (P=0.466) or dialysers (P=0.708), and overall averaged 7200±1700/ml. Leukocyte counts changed significantly during dialysis (P<0.0001), being decreased after 15 min before rebounding to predialysis values by the end of dialysis. The decrease in leukocyte count depended on the dialyser (P<0.0001). The greatest decrease was seen for the dialyser containing Cuprophan membrane (64±18%), followed by those containing Gambrane (51±23%), PMMA ( 43±18%), and cellulose acetate ( 30±16%) membranes. The mag- pre-and postdialysis plasma concentrations of elastasea 1 -proteinase inhibitor. Patients at centre 2 had brane caused a significantly greater increase in concen-significantly greater predialysis concentrations of tration than did those containing cellulose acetate and elastase-a 1 -proteinase inhibitor than patients at the Gambrane membranes, which in turn caused signific-other centres (P<0.001). However, there were no antly greater increases than the dialyser containing diÂerences between any of the dialysers (P=0.956). PMMA membrane. That the increase in concentration All dialysers were associated with leukocyte activation, was caused by the dialyser is shown by the significant as evidenced by a significant increase from pre-to increase between the inlet and outlet of the dialyser postdialysis in the concentration of elastase-a 1 -pro-( Table 6 ). The magnitude of this increase depended on teinase inhibitor ( Table 7 ). The magnitude of the the dialyser (P<0.0001) in the same manner as the increase depended on the dialyser, being significantly changes in the arterial concentration of C3a des Arg.
greater for the dialysers containing Cuprophan and Changes in plasma TCC concentration were similar Gambrane membranes than for the other two dialysers to those seen for C3a des Arg. Plasma concentrations (P<0.05). increased during dialysis (P<0.001) and between the Platelet counts did not diÂer between centres (P= inlet and outlet of the dialyser (P<0.001), and 0.808) or dialysers (P=0.326), predialysis ( Table 8 ) . remained greater than predialysis values at the end of Platelet counts increased significantly during dialysis dialysis (P<0.018) ( Table 6 ). The magnitude of the (P<0.001), but there were no significant diÂerences increase depended on the dialyser, with the change between dialysers (P=0.0565). The increase in platelet observed for the dialyser containing Cuprophan count can be attributed to haemoconcentration, since membrane being significantly greater than those for platelet counts corrected for haemoconcentration by the change in haematocrit did not change during the dialysers containing the other three membranes Predialysis  183±115  231±129  212±145  228±118  15 min Inlet  1823±13773  1285±5153  548±2413  1276±8053  Outlet  5270±31904  3250±18304  1260±8404  3110±20904  Postdialysis  594±2333  479±327  255±117  450±223  TCC  Predialysis  486±197  521±157  512±175  494±151  15 min Inlet  2487±16243  1444±7073  1240±5623  2104±14293  Outlet  6848±28484  2940±12474  2853±12874  4137±23724  Postdialysis  2941±9443  983±8533  1256±4873  1288±4623 1Data are presented as mean±SD for 23 patients. 2Statistical diÂerences between the four dialysers are described in the text. 3Significantly diÂerent from predialysis (P<0.001). 4Significantly diÂerent from dialyser inlet (P<0.001). 1Data are presented as mean±SD for 35 patients. 2Statistical diÂerences between the four membranes are described in the text. 3Significantly diÂerent from predialysis (P<0.001). dialysis (P=0.520) (data not shown). Predialysis tions were significantly higher in patients at centre 2 than in patients at the other centres, possibly reflecting concentrations of TAT were slightly lower in patients at centre 2 than at the other centres (P=0.0002) diÂerent dietary habits in North America and Europe.
All dialysers reduced urea and creatinine concentra-(centre 1, 6.0±3.8 ng/ml; centre 2, 3.2±1.2 ng/ml; centre 3, 5.7±3.5 ng/ml ); however, there were no tions to a similar extent ( Table 4 ). The achieved Kt/V did not diÂer between dialysers and overall was diÂerences between dialysers after adjusting for centre diÂerences (P=0.866). TAT concentrations increased 1.20±0.17, indicating that what is presently considered to be an adequate dialysis can be provided in 3-4 h at significantly during dialysis for all dialysers (P<0.001) ( Table 8 ). The increase in TAT concentration for the blood flow rates of 250-350 ml/min with a range of low-flux membranes. The decrease in Kt/V with dialyser containing Cuprophan membrane was significantly greater than for the dialyser containing cellu-increasing body weight seen in this and other [8] studies suggests, however, that increased blood flow lose acetate membrane (P<0.05). The increases observed for the other two dialysers were intermediate rates and dialysers with high urea clearances may be between these two and did not diÂer significantly insuÃcient to provide an increased Kt/V to large from them.
patients. The dialyser with the synthetic PMMA membrane provided the smallest decrease in phosphate ( Table 4 ) .
Discussion
The diÂerence may reflect charge interactions between the negatively charged phosphate ion and the negatively charged B2 type PMMA membrane [9 ] . In This multicentre clinical study compared the performcontrast, the dialyser containing the other synthetic ance and haemocompatibility of four dialysers conmembrane, Gambrane, yielded a 41% reduction in taining representative low-flux membranes under phosphate, not diÂerent from that achieved with the conditions of current clinical practice. The membranes dialysers containing the cellulosic membranes. comprised the three basic polymer types used for Traditionally, low-flux membranes exhibit high dialysis, regenerated cellulose (Cuprophan), modified small-molecule clearances, but have no ability to cellulose (cellulose acetate), and synthetic ( PMMA and remove large solutes, such as b 2 -microglobulin. The Gambrane), and included hollow-fibre and flat-plate dialysers with cellulose, cellulose acetate, and PMMA formats.
membranes met these criteria. In contrast, the dialyser While the study included patients from diverse geocontaining Gambrane membrane decreased b 2 -micrographical regions and dialysis settings, we found few globulin concentrations by 23±18% (Figure 1 ), while centre-to-centre diÂerences in the parameters measured. Predialysis creatinine and phosphate concentra-providing the same high level of urea and creatinine removal ( Table 4 ). This magnitude of b 2 -microglobulin penia, while the dialyser with PMMA membrane caused the least complement activation, but a similar reduction has so far only been reported for dialysers containing high-flux membranes of polymers such as level of leukopenia to the dialyser with Gambrane membrane. These data suggest a dissociation between polysulphone and polyamide [10 ] . The dialyser containing Gambrane membrane removed suÃcient C3a generation and leukopenia and imply that other factors, such as adsorption of complement fragments b 2 -microglobulin to reduce significantly predialysis b 2 -microglobulin concentrations after 2 weeks of use to the membrane or the ability of the membrane to support formation of the C3a and C5a convertases ( Table 5 ) . Existing high-flux dialysers permit b 2 -microglobulin removal, but at the expense of an increased [20] [21] [22] , play an important role in determining a membrane's impact on leukocyte function. That the water permeability. For example, low-flux membranes of polysulphone and PMMA have in vivo water complement activation and its sequelae is more complex than indicated by changes in the concentration of permeabilities of 5-6 ml/h/m2/mmHg and permit no b 2 -microglobulin removal [11 ] ( Figure 1 ). High-flux C3a des Arg is supported by the finding that changes in TCC concentration for the dialyser with PMMA membranes of the same polymers do permit b 2 -microglobulin removal [11, 12] , but have in vivo water per-membrane did not diÂer from those observed with the dialysers containing cellulose acetate and Gambrane meabilities in the range 30-40 ml/h/m2/mmHg. b 2 -microglobulin removal by high-flux membranes membranes ( Table 6 ). Significant increases in TCC during dialysis with dialysers containing PMMA memoccurs through a combination of convection, adsorption, and diÂusion [12 ] . The b 2 -microglobulin sieving brane have also been described by Haag-Weber et al.
[23]. coeÃcient for Gambrane membrane is about 0.35 [13] . Using an average ultrafiltered volume of 2.82 litres Another discordance between complement and leukocyte activation, namely neutrophil degranulation in ( Table 3 ) , an average plasma b 2 -microglobulin concentration during dialysis with the Gambrane membrane spite of low levels of complement activation, has been reported by Hö rl et al. for dialysers with PMMA of 33 mg/l ( Table 5) , and a sieving coeÃcient of 0.35 yields an average removal of b 2 -microglobulin by con-membrane [24] . In contrast to Hörl et al. we observed very modest increases in the concentrations of both vection of 33 mg. This amount is much less than the estimated removal of 132 mg. Even allowing that we C3a des Arg and elastase-a 1 -proteinase inhibitor for the dialyser with PMMA membrane ( Table 7) . The may have overestimated b 2 -microglobulin removal [14 ] , the discrepancy between the values suggests that reasons for this diÂerence are unknown. Since the dialyser with Gambrane membrane produced significb 2 -microglobulin removal by Gambrane involves more than convection. The segmented microdomain antly less C3a des Arg than the one with Cuprophan membrane (Table 6 ), it seems unlikely that degranulastructure of Gambrane presents a mixed hydrophilichydrophobic surface to blood [15 ] . Based on the tion is solely complement mediated. -microglobulin, while being small enough to pre-Lowrie reported that degranulation occurs at shear rates found in haemodialysis [26 ] . Both dialysers for vent excessive water transport. Further studies will be required to determine which of these mechanisms are which we observed significant elastase-a 1 -proteinase inhibitor release were of the flat-plate format, and it is the most important for b 2 -microglobulin removal. In agreement with previous studies [17 ] , all dialysers possible that this geometry creates localized shear rates that predispose to leukocyte degranulation. activated complement to some extent. Complement was activated the most by the dialyser with Cuprophan None of the dialysers was overtly thrombogenic. Platelet counts did not change and plasma TAT concenmembrane, the dialysers with cellulose acetate and Gambrane membranes were intermediate, and the dia-trations increased only modestly ( Table 8) . Previously we have shown that large increases in the concentration lyser with PMMA membrane activated complement the least ( Table 6 ). The leukopenia observed early in of TAT occur only at much lower levels of anticoagulation than used in this study [27] . Thus, real diÂerences dialysis is thought to be a consequence of complement activation [18 ] , specifically generation of C5a [19] . in thrombogenicity between the dialysers may have been masked by the level of anticoagulation used in Changes in the plasma concentration of C3a des Arg are often used as a marker of the impact of dialyser the study. However, since this level of anticoagulation is typical of that routinely used for haemodialysis, any membranes on leukocytes. Indeed, we observed the greatest increase in plasma C3a des Arg, and the most diÂerences in thrombogenicity revealed at much lower levels of anticoagulation may be considered of limited leukopenia, with the dialyser containing Cuprophan membrane. However, the other three dialysers exhib-clinical relevance.
In summary, our results demonstrate that equivalent ited diÂerent rank orders for complement activation and leukopenia. The dialyser with cellulose acetate small molecule removal can be obtained by dialysers containing a wide range of low-flux membranes. The membrane produced the second highest C3a des Arg concentration, but the second least amount of leuko-uniformity in performance was not sustained as
